Stock Research for ZGNX

Current Price


Latest Update: 2018-03-16 16:00:00

$ 42.1500
$ 42.0000
$ 42.0500

Featured Broker: TradeStation

Get the due diligence for another stock.


ZGNX Stock Chart & Research Data

The ZGNX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ZGNX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


ZGNX Due diligence Resources & Stock Charts

The ZGNX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ZGNX Detailed Price Forecast - CNN Money CNN View ZGNX Detailed Summary - Google Finance
Yahoo View ZGNX Detailed Summary - Yahoo! Finance Zacks View ZGNX Stock Research & Analysis -

Stock Analysis

TradeIdeas View ZGNX Trends & Analysis - Trade-Ideas Barrons View ZGNX Major Holders - Barrons
NASDAQ View ZGNX Call Transcripts - NASDAQ Seeking View ZGNX Breaking News & Analysis - Seeking Alpha
Spotlight View ZGNX Annual Report - OTC Report View ZGNX OTC Short Report -
TradeKing View ZGNX Fundamentals - TradeKing Charts View ZGNX SEC Filings - Bar Chart
WSJ View Historical Prices for ZGNX - The WSJ Morningstar View Performance/Total Return for ZGNX - Morningstar
MarketWatch View the Analyst Estimates for ZGNX - MarketWatch CNBC View the Earnings History for ZGNX - CNBC
StockMarketWatch View the ZGNX Earnings - StockMarketWatch MacroAxis View ZGNX Buy or Sell Recommendations - MacroAxis
Bullish View the ZGNX Bullish Patterns - American Bulls Short Pains View ZGNX Short Pain Metrics -

Social Media Mentions

StockTwits View ZGNX Stock Mentions - StockTwits PennyStocks View ZGNX Stock Mentions - PennyStockTweets
Twitter View ZGNX Stock Mentions - Twitter Invest Hub View ZGNX Investment Forum News - Investor Hub
Yahoo View ZGNX Stock Mentions - Yahoo! Message Board Seeking Alpha View ZGNX Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for ZGNX - Insider Cow View Insider Transactions for ZGNX - Insider Cow
CNBC View ZGNX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ZGNX - OTC Markets
Yahoo View Insider Transactions for ZGNX - Yahoo! Finance NASDAQ View Institutional Holdings for ZGNX - NASDAQ

Stock Charts

FinViz View ZGNX Stock Insight & Charts - StockCharts View ZGNX Investment Charts -
BarChart View ZGNX Stock Overview & Charts - BarChart Trading View View ZGNX User Generated Charts - Trading View

Latest Financial News for ZGNX

Employee Stock Options Liability Significant For Zogenix
Posted on Friday March 09, 2018

From yesterday's research, analysts parsed 49 10-K filings and collected 6,142 data points. In total, they made 1,001 forensic accounting adjustments with a dollar value of $99 billion. The Robo-Analyst found an unusual item yesterday in Zogenix’s (ZGNX) 10-K.

Zogenix reports 4Q loss
Posted on Wednesday March 07, 2018

On a per-share basis, the Emeryville, California-based company said it had a loss of $1.17. Losses, adjusted for one-time gains and costs, came to $1.14 per share. The results missed Wall Street expectations. ...

Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2017 Financial Results
Posted on Tuesday March 06, 2018

ZX008 Granted Breakthrough Therapy Designation in Dravet syndrome by FDA Last patient randomized into second Phase 3 clinical trial of ZX008 in patients with Dravet syndrome, Study 1504 Initiated global ...

Why Zogenix Inc. Shares Shot Up 16.6% in February
Posted on Tuesday March 06, 2018

This company's epilepsy drug candidate may be better than a marijuana-based treatment awaiting an FDA decision.

Warning: DOMDocument::load( failed to open stream: HTTP request failed! HTTP/1.0 404 Not Found in /home/allsites/ on line 494

Warning: DOMDocument::load(): I/O warning : failed to load external entity "" in /home/allsites/ on line 494

Enter a stock symbol to view the stock details.